| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
126,890,000 |
| Market
Cap: |
1.15(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$9.07 - $9.1 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
| |
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile CTI BioPharma is a biopharmaceutical company focused on the acquisition, development and commercialization of targeted therapies for blood-related cancers where there is an unmet medical need. Co. has one commercially approved product, VONJO™ (pacritinib), which has received approval in the U.S. by the U.S. Food and Drug Administration for the treatment of adult patients with intermediate or primary or secondary (post-polycythemia vera or post-essential thrombocythemia) myelofibrosis with a platelet count below 50 x 10^9/L.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
5,000 |
| Total Buy Value |
$0 |
$0 |
$0 |
$27,500 |
| Total People Bought |
0 |
0 |
0 |
1 |
| Total Buy Transactions |
0 |
0 |
0 |
1 |
| Total Shares Sold |
0 |
0 |
0 |
9,840,628 |
| Total Sell Value |
$0 |
$0 |
$0 |
$60,171,858 |
| Total People Sold |
0 |
0 |
0 |
5 |
| Total Sell Transactions |
0 |
0 |
0 |
25 |
| End Date |
2024-03-17 |
2023-12-15 |
2023-06-16 |
2022-06-16 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Bianco Louis A |
EVP, Finance & Administration |
• – – |
2007-12-14 |
4 |
AS |
$1.99 |
$1,493 |
D/D |
(750) |
100,316 |
|
- |
|
| Telling Fred |
Director |
– • – |
2007-09-25 |
4 |
A |
$0.00 |
$0 |
D/D |
3,000 |
3,625 |
|
- |
|
| Nudelman Phillip M Phd |
Director |
– • – |
2007-09-25 |
4 |
A |
$0.00 |
$0 |
D/D |
3,000 |
16,726 |
|
- |
|
| Mundinger Mary Oneil |
Director |
– • – |
2007-09-25 |
4 |
A |
$0.00 |
$0 |
D/D |
3,000 |
4,663 |
|
- |
|
| Gregorian Vartan |
Director |
– • – |
2007-09-25 |
4 |
A |
$0.00 |
$0 |
D/D |
3,000 |
5,500 |
|
- |
|
| Bauer John H |
Director |
– • – |
2007-09-25 |
4 |
A |
$0.00 |
$0 |
D/D |
3,000 |
4,250 |
|
- |
|
| Love Richard L |
Director |
– • – |
2007-09-25 |
4 |
A |
$0.00 |
$0 |
D/D |
3,000 |
496,996 |
|
- |
|
| Eramian Daniel G |
EVP, Corporate Communications |
• – – |
2007-09-25 |
4 |
A |
$0.00 |
$0 |
D/D |
70,563 |
84,313 |
|
- |
|
| Stromatt Scott |
EVP, Clinical Dev & Reg Affair |
• – – |
2007-09-25 |
4 |
A |
$0.00 |
$0 |
D/D |
70,563 |
76,188 |
|
- |
|
| Singer Jack W |
EVP, Chief Medical Officer |
• • – |
2007-09-25 |
4 |
A |
$0.00 |
$0 |
D/D |
84,675 |
168,841 |
|
- |
|
| Bianco Louis A |
EVP, Finance & Administration |
• – – |
2007-09-25 |
4 |
A |
$0.00 |
$0 |
D/D |
84,675 |
101,066 |
|
- |
|
| Bianco James A |
President And CEO |
• • – |
2007-09-25 |
4 |
A |
$0.00 |
$0 |
D/D |
282,257 |
375,777 |
|
- |
|
| Love Richard L |
Director |
– • – |
2007-09-21 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
490,996 |
|
- |
|
| Love Richard L |
Director |
– • – |
2007-09-21 |
4 |
A |
$0.00 |
$0 |
D/D |
3,000 |
493,996 |
|
- |
|
| Stromatt Scott |
EVP, Clinical Dev & Reg Affair |
• – – |
2007-08-31 |
4 |
AS |
$3.87 |
$2,419 |
D/D |
(625) |
5,625 |
|
- |
|
| Bianco Louis A |
EVP, Finance & Administration |
• – – |
2007-06-14 |
4 |
S |
$3.48 |
$2,610 |
D/D |
(750) |
16,391 |
|
- |
|
| Singer Jack W |
EVP, Chief Medical Officer |
• • – |
2007-06-14 |
4 |
S |
$3.46 |
$2,427 |
D/D |
(700) |
84,166 |
|
- |
|
| Nudelman Phillip M Phd |
Director |
– • – |
2007-04-18 |
4 |
A |
$0.00 |
$0 |
D/D |
625 |
13,726 |
|
- |
|
| Mundinger Mary Oneil |
Director |
– • – |
2007-04-09 |
4 |
A |
$0.00 |
$0 |
D/D |
2,500 |
6,650 |
|
- |
|
| Bianco James A |
President and CEO |
• • – |
2007-03-27 |
4 |
S |
$1.60 |
$56,000 |
D/D |
(35,000) |
374,079 |
|
- |
|
| Bianco Louis A |
EVP, Finance & Administration |
• – – |
2007-03-26 |
4 |
S |
$1.58 |
$47,520 |
D/D |
(30,000) |
68,564 |
|
- |
|
| Bianco James A |
President and CEO |
• • – |
2007-03-26 |
4 |
S |
$1.60 |
$65,184 |
D/D |
(40,740) |
409,079 |
|
- |
|
| Bianco James A |
President and CEO |
• • – |
2007-01-02 |
4 |
GD |
$0.00 |
$0 |
D/D |
6,667 |
449,819 |
|
- |
|
| Bianco Louis A |
EVP, Finance & Administration |
• – – |
2007-01-01 |
4 |
D |
$0.00 |
$0 |
D/D |
(100,000) |
98,564 |
|
- |
|
| Singer Jack W |
EVP, Chief Medical Officer |
• • – |
2007-01-01 |
4 |
D |
$0.00 |
$0 |
D/D |
(100,000) |
339,465 |
|
- |
|
742 Records found
|
|
Page 25 of 30 |
|
|
